4.7 Review

A systematic review and meta-analysis of the effects of antipsychotic medications on regional cerebral blood flow (rCBF) in schizophrenia: Association with response to treatment

Journal

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
Volume 43, Issue -, Pages 118-136

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neubiorev.2014.03.014

Keywords

Schizophrenia; Psychosis; Resting cerebral blood flow (rCBF); Antipsychotic; Neuroimaging; Treatment response; Neurophysiology

Funding

  1. Medical Research Council [1097247, MR/J008915/1] Funding Source: researchfish
  2. Medical Research Foundation [C0439] Funding Source: researchfish
  3. MRC [MR/J008915/1] Funding Source: UKRI
  4. Medical Research Council [MR/J008915/1] Funding Source: Medline
  5. MRF [MRF_C0439] Funding Source: Medline

Ask authors/readers for more resources

Evaluating the short- and long-term effects of antipsychotics on brain physiology is a key factor in advancing our understanding of neurophysiological changes in psychosis and improving prediction of treatment response. Understanding the nature of such changes is crucial to the interpretation of neuroimaging findings in patients with schizophrenia and psychoses in general. This review has systematically appraised existing evidence on resting cerebral blood flow (rCBF) in schizophrenia, before and after antipsychotic treatment, relating the findings to symptom severity. The review shows that antipsychotics exert regional effects on rCBF, particularly in frontal and basal ganglia regions, and that different antipsychotic generations have differential effects on rCBF. These findings are supported by an exploratory meta-analysis of a subset of studies. The review also highlights the relative lack of studies that use a priori definitions of treatment response, which is an important step in identifying testable hypotheses and ensuring clinical relevance of remission criteria. Finally, the review highlights important considerations for future psychopharmacological studies investigating the potential for rCBF to predict symptomatic improvement, which could inform the management of treatment in schizophrenia. (C) 2014 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available